Tarsons Products Limited — Investor Meet, 17-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Tarsons Products Limited reported Q1 FY27 consolidated revenue of INR 110 Cr (+21% YoY), with standalone revenue at INR 86 Cr (+21% YoY). Domestic sales grew 17% and exports surged 29%. Gross margins (standalone 67.1%) and consolidated EBITDA (INR 26 Cr, 23.6% margin) were impacted by higher raw material costs and new facility expenses. Cash profit grew 18% YoY to INR 25.6 Cr.

Management foresees strong demand recovery, targeting 15%+ growth, driven by existing products, new capacities, and international expansion. Full commissioning of new facilities is expected in Q2, contributing from H2 FY27. Exports are recovering, with white labeling as a key growth driver. Pricing adjustments are underway to counter significant raw material cost increases. Profitability is expected to moderate in FY27 due to CAPEX-related costs, improving as new facilities ramp up, aiming for 20-25% of standalone revenue from new facilities by FY28.

Debt stands at INR 380 Cr gross, with a target to reduce net debt by ~INR 40 Cr this year. FY27 depreciation is projected to peak at INR 105-110 Cr. Raw material prices remain volatile, and export challenges persist from tariffs and logistics, though inquiries are strong. Tarsons is focused on leveraging expanded capabilities for sustainable growth and market penetration, with an optimistic outlook.